ArticleJournal of pharmacokinetics and pharmacodynamics2012

Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab.

Brittany P Kay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.